Other | Minimal Risk

Norethisterone (Primolut N)

What to know about Norethisterone — also sold as Primolut N, Noriday 28 Day: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

Norethisterone (brand names: Primolut N, Noriday 28 Day) is classified as Minimal risk by AllMeds. It is a S4 medication under the TGA in Australia. Progestogen hormone with minimal risk for work capacity impairment.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Minimal (0 points)
  • PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 PBS listed

Risk Profile

Risk Level Minimal
Risk Points 0
CNS Depressant No
Respiratory Risk No

Progestogen hormone with minimal risk for work capacity impairment.

How Norethisterone is regulated

Norethisterone is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.

Check this medication against your full medication list

Run a full risk assessment including Norethisterone interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.